Neehar Dilip Parikh MD, MS
Li Ka Shing Research Professor of Hepatology
Associate Professor of Internal Medicine
Medical Director, Hepatology Living Donor Transplant, Medical School
Email:
[email protected]
Available to mentor
Neehar Dilip Parikh MD, MS
Associate Professor
Manage Your Profile
Center Memberships
-
Center MemberInstitute for Healthcare Policy and Innovation
Recent Publications
-
Welch N, Smith A, Tincopa M, Hameed B, Bajaj JS, Cullaro G, Dinani AM, Goldberg D, Jones PD, Kardashian A, Khalili M, Loomba R, Parikh N, Simonetto DA, Verna E, Wegermann K, Terrault N, Dasarathy S, Sterling R. The American Journal of Gastroenterology, 2026 Oct 9; 121 (10S1): s551 - s552.Journal ArticleS2527 Agreement Among Non-Invasive Liver Disease Assessments (NILDA) in Compensated Cirrhosis: Experience From the Liver Cirrhosis Network (LCN)
DOI:10.14309/01.ajg.0001219360.78472.ea -
Singal AG, Saborowski A, Parikh ND, Banales JM. Journal of Hepatology, 2026 Oct 1; 85 (4): 683 - 694.Journal ArticleThe future of blood-based biomarkers in liver cancer
DOI:10.1016/j.jhep.2026.03.040 PMID: 42601275 -
Kanwal F, Lopez C, Ning J, Luster M, Reddy KR, Parikh ND, Singal AG, Marrero JA, Chhatwal J, Feng Z, Page-Lester S, Koay EJ, El-Serag HB. Clinical Gastroenterology and Hepatology, 2026 Oct 1; 24 (10): 2724 - 2731.Journal ArticleValidation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study
DOI:10.1016/j.cgh.2026.01.041 PMID: 41672261 -
Yarchoan M, Llovet JM, Kelley RK, Finn R, Parikh ND, Tabrizian P, Burgoyne AM, Agopian VG, Sanford NN, Tran Cao HS, Padia SA, Vogel A, Lewandowski RJ, Kirema G-R, Lin R, Mehta N, Sapisochin G, Yopp A, Villanueva A, Halazun K, Pinato DJ, Kim E, Heimbach JK, Pillai A, Salem R, El-Khoueiry A, Singal AG. Gut, 2026 Sep 24;Journal ArticleExpert consensus on clinical trials for use of systemic therapy in patients with hepatocellular carcinoma undergoing surgical and locoregional therapies.
DOI:10.1136/gutjnl-2026-339505 PMID: 42785981 -
Worlikar T, Caoili E, Navarro A, Loudon N, Nalla A, Khaykin VM, Hudson E, Hunold T, Parikh ND, Mendiratta-Lala M. Journal of Vascular and Interventional Radiology, 2026 Sep 1; 37 (9):Journal ArticleManagement and Prevention of Histotripsy-Induced Acute Bland Portal Vein Thrombosis in Histotripsy-Treated Liver Tumors
DOI:10.1016/j.jvir.2026.108883 PMID: 42235819 -
Choi WJ, Ivanics T, Claasen M, Magyar CTJ, Li Z, Tabrizian P, Rocha C, Myers B, O'kane GM, Reig M, Fàbrega JF, Holguín V, Parikh ND, Pillai A, Hunold TM, Vogel A, Patel MS, Singal AG, Tadros M, Feld JJ, Hansen B, Sapisochin G. Surgery United States, 2026 Aug 1; 196:Journal ArticleCorrigendum to: Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international study (Surgery (2025) 183 (109396) PII: S003960602500248X DOI: 10.1016/j.surg.2025.109396)
DOI:10.1016/j.surg.2026.110228 PMID: 42215358 -
Parikh ND, Singal AG. Gastroenterology, 2026 Aug 1; 171 (2): 388 - 389.Journal ArticleNot So Fast, My Friend: Biomarkers May Play an Important Role in Hepatocellular Carcinoma Surveillance
DOI:10.1053/j.gastro.2026.03.029 PMID: 42066861 -
Seif El Dahan K, Daher D, Rich NE, Nayak AJ, Ankoma-Sey C, Govalan R, Bhongade MB, Molina E, Amador E, Pitts H, Jalal PK, Kanwal F, Parikh ND, Singal AG. Hepatology, 2026 Jul 22; 83 (6): 1446 - 1455.Journal ArticleCauses of mortality among patients with early-stage hepatocellular carcinoma
DOI:10.1097/HEP.0000000000001471 PMID: 40694813
Featured News & Stories
Health Lab
Exceptional response to immunotherapy gives patient with liver cancer more milestones to celebrate
U-M Health Rogel Cancer Center used single-dose immunotherapy and transplant oncology to treat advanced hepatocellular carcinoma in a 69-year-old patient.
Health Lab
Liver cancer can be preventable. Do you know the treatable risk factors?
Learn about the risks of chronic liver disease, the treatable liver disease factors and how rates of liver cancer have increased.
Department News
Faculty Spotlight - Neehar Parikh, MD, MS
Meet Dr. Neehar Parikh, a specialist in liver disease and liver cancer. Dr. Parikh also is a faculty advisor for the U-M Health Rogel Cancer Center Community Outreach & Engagement Program.
Health Lab
Doctors perform first liver transplant in Michigan for colon cancer
Andrew Sweeney was diagnosed with stage 4 colorectal cancer at age 31 and underwent a liver transplant, chemotherapy and radiation treatment.
Cancer Aware
Cutting edge treatment for advanced colon cancer
Andrew Sweeney, now 35, was aware of his risk for colorectal cancer – his mother had had been diagnosed with it when she was 41. When he was 31, a CT scan at University of Michigan Health’s University Hospital revealed that Sweeney had a mass in his colon and potential metastases in his liver and lymph nodes. A colonoscopy confirmed that he had stage 4 colorectal cancer.
After 1.5 years of chemotherapy, his care team began discussing how they could remove the damaged parts of Sweeney’s liver. They developed a colorectal cancer liver transplant protocol from a deceased donor and Sweeney was the first patient to undergo a liver transplant in Michigan for colon cancer. After minor recurrences of tumors in his lung in 2024, which were treated by surgery and radiation, his scans have been clear.
Great Minds, Greater Discoveries Stories
Research Impact: Histotripsy
In late 2023, the United States Food and Drug Administration (FDA) approved the use of sound waves to break down tumors — a technique called histotripsy — in humans for liver treatment, a new therapy developed at the University of Michigan and with support from the National Institutes of Health.
